Milton L. Brown, Brookeville, MD (US); Yali Kong, Fairfax, VA (US); Courtney Houchen, Edmond, OK (US); Sripathi M. Sureban, Oklahoma City, OK (US); and Parthasarathy Chandrakesan, Edmond, OK (US)
Assigned to Georgetown University, Washington, DC (US); and The Board of Regents of the University of Oklahoma, Norman, OK (US)
Filed by Georgetown University, Washington, DC (US); and The Board of Regents of the University of Oklahoma, Norman, OK (US)
Filed on Jun. 8, 2023, as Appl. No. 18/207,447.
Application 18/207,447 is a division of application No. 17/728,485, filed on Apr. 25, 2022, granted, now 11,672,789.
Application 17/728,485 is a continuation of application No. 16/089,794, granted, now 11,311,526, previously published as PCT/US2017/025440, filed on Mar. 31, 2017.
Claims priority of provisional application 62/316,121, filed on Mar. 31, 2016.
Prior Publication US 2023/0310407 A1, Oct. 5, 2023
1. A method for treating or preventing radiation-induced tissue injury, comprising administering to a subject in need thereof a therapeutically effective amount of a compound represented by formula II
or a pharmaceutically acceptable salt thereof, thereby treating or preventing radiation-induced tissue injury in the subject.
